About DNA Sequencing
DNA sequencing is the process of determining the precise order of the four nucleotides, namely, adenine, guanine, cytosine, and thymine, in a strand of DNA.
Technavio’s analysts forecast the global DNA sequencing market to grow at a CAGR of 20.93% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global DNA sequencing market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales DNA sequencing.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• BGI
• F. Hoffmann-La Roche
• Illumina
• Pacific Biosciences of California
• Thermo Fisher Scientific
Market driver
• The all-inclusive cost structure of sequencing products
• For a full, detailed list, view our report
Market challenge
• Difficulties in clinical interpretations and inadequate reimbursements
• For a full, detailed list, view our report
Market trend
• Growth of the bioinformatics tools that make DNA sequencing easy
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Comparison by product
• Global DNA sequencing market by services
• Global DNA sequencing market by instruments, reagents, and consumables
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Regional comparison
• DNA sequencing market in Americas
• DNA sequencing market in EMEA
• DNA sequencing market in APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Bioinformatics tools making DNA sequencing easy
• Increasing adoption in clinical workflows
• Increasing incidence of chronic diseases
• Growing demand for high-accuracy forensic tools
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• BGI
• F. Hoffmann-La Roche
• Illumina
• Pacific Biosciences of California
• Thermo Fisher Scientific
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Global genomics market
Exhibit 02: Global genomics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Cost of sequencing per genome in $ (2001-2015)
Exhibit 06: Market definition: Inclusions and exclusions checklist
Exhibit 07: Global DNA sequencing market
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global DNA sequencing market 2017-2022 ($ billions)
Exhibit 10: Global DNA sequencing market: Year over year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Market condition: Five forces 2022
Exhibit 19: Global DNA sequencing market by product 2017-2022 (% share)
Exhibit 20: Comparison by product
Exhibit 21: Global DNA sequencing market by services 2017-2022 ($ billions)
Exhibit 22: Global DNA sequencing market by services: Year over year growth 2018-2022 (%)
Exhibit 23: Global DNA sequencing market by instruments, reagents, and consumables 2017-2022 ($ billions)
Exhibit 24: Global DNA sequencing market by instruments, reagents, and consumables: Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global DNA sequencing market by region 2017-2022 (% share)
Exhibit 28: Regional comparison
Exhibit 29: Cardiovascular statistics in US
Exhibit 30: DNA sequencing market in Americas: 2017-2022 ($ billions)
Exhibit 31: DNA sequencing market in Americas: Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: DNA sequencing market in EMEA: 2017-2022 ($ billions)
Exhibit 34: DNA sequencing market in EMEA: Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: DNA sequencing market in APAC: 2017-2022 ($ billions)
Exhibit 37: DNA sequencing market in APAC: Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Major M&A in global DNA sequencing market between 2007-2014
Exhibit 41: R&D funding for chronic diseases 2013-2016 ($ millions)
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: BGI: Overview
Exhibit 48: BGI: Business segments
Exhibit 49: BGI: Organizational developments
Exhibit 50: BGI: Geographic focus
Exhibit 51: BGI: Segment focus
Exhibit 52: BGI: Key offerings
Exhibit 53: F. Hoffmann-La Roche: Overview
Exhibit 54: F. Hoffmann-La Roche: Business segments
Exhibit 55: F. Hoffmann-La Roche: Organizational developments
Exhibit 56: F. Hoffmann-La Roche: Geographic focus
Exhibit 57: F. Hoffmann-La Roche: Segment focus
Exhibit 58: F. Hoffmann-La Roche: Key offerings
Exhibit 59: Illumina: Overview
Exhibit 60: Illumina: Business segments
Exhibit 61: Illumina: Organizational developments
Exhibit 62: Illumina: Geographic focus
Exhibit 63: Illumina: Segment focus
Exhibit 64: Illumina: Key offerings
Exhibit 65: Pacific Biosciences of California: Overview
Exhibit 66: Pacific Biosciences of California: Business segments
Exhibit 67: Pacific Biosciences of California: Organizational developments
Exhibit 68: Pacific Biosciences of California: Geographic focus
Exhibit 69: Pacific Biosciences of California: Segment focus
Exhibit 70: Pacific Biosciences of California: Key offerings
Exhibit 71: Thermo Fisher Scientific: Overview
Exhibit 72: Thermo Fisher Scientific: Business segments
Exhibit 73: Thermo Fisher Scientific: Organizational developments
Exhibit 74: Thermo Fisher Scientific: Geographic focus
Exhibit 75: Thermo Fisher Scientific: Segment focus
Exhibit 76: Thermo Fisher Scientific: Key offerings
